Literature DB >> 12145801

Psychiatric disorders among veterans with hepatitis C infection.

Hashem B el-Serag1, Mark Kunik, Peter Richardson, Linda Rabeneck.   

Abstract

BACKGROUND & AIMS: The presence of psychiatric, drug-, and alcohol-use disorders in hepatitis C virus (HCV)-infected patients may influence their management and prognosis. The frequency and the risk for these disorders among HCV-infected patients are unknown.
METHODS: We identified all HCV-infected veteran patients who were hospitalized during 1992-1999 and searched the inpatient and outpatient computerized files for predefined psychiatric, drug-, and/or alcohol-use disorders. We then performed a case-control study among Vietnam veterans; controls without HCV were randomly chosen from hospitalized patients.
RESULTS: We identified 33,824 HCV-infected patients, in whom 86.4% had at least one past or present psychiatric, drug-, or alcohol-use disorder recorded. However, only 31% had active disorders as defined by hospitalization to psychiatric or drug-detoxification bed sections. There were 22,341 HCV-infected patients from the Vietnam period of service (cases) who were compared with 43,267 patients without HCV (controls). Cases were more likely to have depressive disorders (49.5% vs. 39.1%), posttraumatic stress disorder (PTSD) (33.5% vs. 24.5%), psychosis (23.7% vs. 20.9%), bipolar disorder (16.0% vs. 12.6%), anxiety disorders (40.8% vs. 32.9%), alcohol (77.6% vs. 45.0%), and drug-use disorders (69.4% vs. 31.1%). In multivariable regression analyses that adjust for age, sex, and ethnicity, drug use, alcohol-use, depression, PTSD, and anxiety remained strongly associated with HCV.
CONCLUSIONS: Several psychiatric, drug-, and alcohol-use disorders are commonly found among HCV-infected veterans compared with those who are not infected. At least one third of these patients have active disorders. A multidisciplinary approach to the management of HCV-infected patients is needed.

Entities:  

Mesh:

Year:  2002        PMID: 12145801     DOI: 10.1053/gast.2002.34750

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  69 in total

1.  Trauma, dissociation, and antiretroviral adherence among persons living with HIV/AIDS.

Authors:  Alex S Keuroghlian; Charles S Kamen; Eric Neri; Susanne Lee; Rhianon Liu; Cheryl Gore-Felton
Journal:  J Psychiatr Res       Date:  2011-06-01       Impact factor: 4.791

2.  Effect of pegylated interferon-α-2a treatment on mental health during recent hepatitis C virus infection.

Authors:  Maryam Alavi; Jason Grebely; Gail V Matthews; Kathy Petoumenos; Barbara Yeung; Carolyn Day; Andrew R Lloyd; Ingrid Van Beek; John M Kaldor; Margaret Hellard; Gregory J Dore; Paul S Haber
Journal:  J Gastroenterol Hepatol       Date:  2012-05       Impact factor: 4.029

3.  Correlates of hazardous drinking among Veterans with and without hepatitis C.

Authors:  Megan Oser; Michael Cucciare; John McKellar; Kenneth Weingardt
Journal:  J Behav Med       Date:  2012-01-11

4.  Hepatitis C virus infection is associated with painful symptoms in HIV-infected adults.

Authors:  Judith I Tsui; Debbie M Cheng; Howard Libman; Carly Bridden; Jeffrey Samet
Journal:  AIDS Care       Date:  2012-01-24

5.  Barriers to accessing care in patients with chronic hepatitis C: the impact of depression.

Authors:  D M Evon; K M Simpson; D Esserman; A Verma; S Smith; M W Fried
Journal:  Aliment Pharmacol Ther       Date:  2010-09-17       Impact factor: 8.171

6.  Interferon-alpha treatment of patients with Hepatitis C: the role of a comprehensive risk-benefit assessment.

Authors:  Muhamad Aly Rifai; Jennifer M Loftis; Peter Hauser
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

7.  Psychiatric care of the patient with hepatitis C: a review of the literature.

Authors:  Muhamad Aly Rifai; Ondria C Gleason; Douha Sabouni
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

8.  Determinants of antiviral treatment initiation in a hepatitis C-infected population benefiting from universal health care coverage.

Authors:  Romain Moirand; Marc Bilodeau; Suzanne Brissette; Julie Bruneau
Journal:  Can J Gastroenterol       Date:  2007-06       Impact factor: 3.522

9.  Racial differences in the evaluation and treatment of hepatitis C among veterans: a retrospective cohort study.

Authors:  Christine M Rousseau; George N Ioannou; Jeffrey A Todd-Stenberg; Kevin L Sloan; Meaghan F Larson; Christopher W Forsberg; Jason A Dominitz
Journal:  Am J Public Health       Date:  2008-04-01       Impact factor: 9.308

10.  Increased all-cause, liver, and cardiac mortality among hepatitis C virus-seropositive blood donors.

Authors:  Anne M Guiltinan; Zhanna Kaidarova; Brian Custer; Jennie Orland; Angela Strollo; Sherri Cyrus; Michael P Busch; Edward L Murphy
Journal:  Am J Epidemiol       Date:  2008-01-17       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.